N-Sulfonylated and N-alkylated carprofen derivatives wereinvestigated for their inhibition and modulation of
-secretase, whichis associated with Alzheimer's disease. The introduction of a lipophilicsubstituent transformed the COX-2 inhibitor carprofen into a potent
-secretase modulator. Several compounds (e.g.,
9p,
11f) causedselective reduction of A
42 and an increase of A
38. The most activecompounds displayed activities in the low micromolar range and noeffect on the
-secretase cleavage at the
-site.